Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biophys J
2009 Jan 01;961:116-31. doi: 10.1016/j.bpj.2008.09.017.
Show Gene links
Show Anatomy links
Magainin 2 revisited: a test of the quantitative model for the all-or-none permeabilization of phospholipid vesicles.
Gregory SM
,
Pokorny A
,
Almeida PF
.
???displayArticle.abstract???
The all-or-none kinetic model that we recently proposed for the antimicrobial peptide cecropin A is tested here for magainin 2. In mixtures of phosphatidylcholine (PC)/phosphatidylglycerol (PG) 50:50 and 70:30, release of contents from lipid vesicles occurs in an all-or-none fashion and the differences between PC/PG 50:50 and 70:30 can be ascribed mainly to differences in binding, which was determined independently and is approximately 20 times greater to PC/PG 50:50 than to 70:30. Only one variable parameter, beta, corresponding to the ratio of the rates of pore opening to pore closing, is used to fit dye release kinetics from these two mixtures, for several peptide/lipid ratios ranging from 1:25 to 1:200. However, unlike for cecropin A where it stays almost constant, beta increases five times as the PG content of the vesicles increases from 30 to 50%. Thus, magainin 2 is more sensitive to anionic lipid content than cecropin A. But overall, magainin follows the same all-or-none kinetic model as cecropin A in these lipid mixtures, with slightly different parameter values. When the PG content is reduced to 20 mol %, dye release becomes very low; the mechanism appears to change, and is consistent with a graded kinetic model. We suggest that the peptide may be inducing formation of PG domains. In either mechanism, no peptide oligomerization occurs and magainin catalyzes dye release in proportion to its concentration on the membrane in a peptide state that we call a pore. We envision this structure as a chaotic or stochastic type of pore, involving both lipids and peptides, not a well-defined, peptide-lined channel.
Axelsen,
A chaotic pore model of polypeptide antibiotic action.
2008, Pubmed
Axelsen,
A chaotic pore model of polypeptide antibiotic action.
2008,
Pubmed
BARTLETT,
Phosphorus assay in column chromatography.
1959,
Pubmed
Bechinger,
Structure and interactions of magainin antibiotic peptides in lipid bilayers: a solid-state nuclear magnetic resonance investigation.
1992,
Pubmed
,
Xenbase
Bechinger,
Orientations of amphipathic helical peptides in membrane bilayers determined by solid-state NMR spectroscopy.
1991,
Pubmed
,
Xenbase
Bechinger,
Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy.
1993,
Pubmed
,
Xenbase
Bechinger,
Membrane helix orientation from linear dichroism of infrared attenuated total reflection spectra.
1999,
Pubmed
,
Xenbase
Bechinger,
Detergent-like properties of magainin antibiotic peptides: a 31P solid-state NMR spectroscopy study.
2005,
Pubmed
Bessalle,
All-D-magainin: chirality, antimicrobial activity and proteolytic resistance.
1990,
Pubmed
,
Xenbase
Dempsey,
Enhanced membrane permeabilization and antibacterial activity of a disulfide-dimerized magainin analogue.
2003,
Pubmed
,
Xenbase
Evans,
Dynamic tension spectroscopy and strength of biomembranes.
2003,
Pubmed
Frazier,
Investigation of domain formation in sphingomyelin/cholesterol/POPC mixtures by fluorescence resonance energy transfer and Monte Carlo simulations.
2007,
Pubmed
Gesell,
Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution.
1997,
Pubmed
,
Xenbase
Grant,
Mechanism of magainin 2a induced permeabilization of phospholipid vesicles.
1992,
Pubmed
,
Xenbase
Gregory,
A quantitative model for the all-or-none permeabilization of phospholipid vesicles by the antimicrobial peptide cecropin A.
2008,
Pubmed
Hallock,
MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain.
2003,
Pubmed
,
Xenbase
Hara,
Heterodimer formation between the antimicrobial peptides magainin 2 and PGLa in lipid bilayers: a cross-linking study.
2001,
Pubmed
,
Xenbase
Haukland,
The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm.
2001,
Pubmed
,
Xenbase
Hinderliter,
Domain formation in a fluid mixed lipid bilayer modulated through binding of the C2 protein motif.
2001,
Pubmed
Huang,
Action of antimicrobial peptides: two-state model.
2000,
Pubmed
Huang,
Molecular mechanism of Peptide-induced pores in membranes.
2004,
Pubmed
Jo,
Insertion of magainin into the lipid bilayer detected using lipid photolabels.
1998,
Pubmed
Juretić,
Magainin oligomers reversibly dissipate delta microH+ in cytochrome oxidase liposomes.
1994,
Pubmed
,
Xenbase
Karatekin,
Cascades of transient pores in giant vesicles: line tension and transport.
2003,
Pubmed
Ladokhin,
Leakage of membrane vesicle contents: determination of mechanism using fluorescence requenching.
1995,
Pubmed
Ladokhin,
Mechanism of leakage of contents of membrane vesicles determined by fluorescence requenching.
1997,
Pubmed
Lee,
Energetics of pore formation induced by membrane active peptides.
2004,
Pubmed
Leontiadou,
Antimicrobial peptides in action.
2006,
Pubmed
Li,
Structure of magainin and alamethicin in model membranes studied by x-ray reflectivity.
2006,
Pubmed
,
Xenbase
Ludtke,
Cooperative membrane insertion of magainin correlated with its cytolytic activity.
1994,
Pubmed
,
Xenbase
Ludtke,
Membrane thinning caused by magainin 2.
1995,
Pubmed
,
Xenbase
Ludtke,
Membrane pores induced by magainin.
1996,
Pubmed
,
Xenbase
Maloy,
Structure-activity studies on magainins and other host defense peptides.
1995,
Pubmed
Marion,
A two-dimensional NMR study of the antimicrobial peptide magainin 2.
1988,
Pubmed
,
Xenbase
Matsuzaki,
Magainin 1-induced leakage of entrapped calcein out of negatively-charged lipid vesicles.
1989,
Pubmed
,
Xenbase
Matsuzaki,
Orientational and aggregational states of magainin 2 in phospholipid bilayers.
1994,
Pubmed
,
Xenbase
Matsuzaki,
Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2.
1995,
Pubmed
,
Xenbase
Matsuzaki,
Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore.
1995,
Pubmed
,
Xenbase
Matsuzaki,
Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers.
1995,
Pubmed
,
Xenbase
Matsuzaki,
An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation.
1996,
Pubmed
,
Xenbase
Matsuzaki,
Modulation of magainin 2-lipid bilayer interactions by peptide charge.
1997,
Pubmed
,
Xenbase
Matsuzaki,
Relationship of membrane curvature to the formation of pores by magainin 2.
1998,
Pubmed
,
Xenbase
Matsuzaki,
Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa.
1998,
Pubmed
,
Xenbase
Müller,
Continuous measurement of rapid transbilayer movement of a pyrene-labeled phospholipid analogue.
2000,
Pubmed
,
Xenbase
Münster,
Magainin 2 in phospholipid bilayers: peptide orientation and lipid chain ordering studied by X-ray diffraction.
2002,
Pubmed
,
Xenbase
Nishida,
Interaction of a magainin-PGLa hybrid peptide with membranes: insight into the mechanism of synergism.
2007,
Pubmed
,
Xenbase
Parente,
Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA.
1990,
Pubmed
Pokorny,
Kinetics of dye efflux and lipid flip-flop induced by delta-lysin in phosphatidylcholine vesicles and the mechanism of graded release by amphipathic, alpha-helical peptides.
2004,
Pubmed
Pokorny,
Mechanism and kinetics of delta-lysin interaction with phospholipid vesicles.
2002,
Pubmed
Porcelli,
Structures of the dimeric and monomeric variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR spectroscopy.
2006,
Pubmed
Pouny,
Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes.
1992,
Pubmed
Puech,
Line thermodynamics: adsorption at a membrane edge.
2003,
Pubmed
Rapaport,
Reversible surface aggregation in pore formation by pardaxin.
1996,
Pubmed
Rathinakumar,
Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes.
2008,
Pubmed
Rosenfeld,
Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis.
2006,
Pubmed
Schümann,
The tendency of magainin to associate upon binding to phospholipid bilayers.
1997,
Pubmed
,
Xenbase
Shai,
Mode of action of membrane active antimicrobial peptides.
2002,
Pubmed
Tamba,
Single giant unilamellar vesicle method reveals effect of antimicrobial peptide magainin 2 on membrane permeability.
2005,
Pubmed
,
Xenbase
Tieleman,
Simulation of pore formation in lipid bilayers by mechanical stress and electric fields.
2003,
Pubmed
Tieleman,
Lipids out of equilibrium: energetics of desorption and pore mediated flip-flop.
2006,
Pubmed
Tremouilhac,
Synergistic transmembrane alignment of the antimicrobial heterodimer PGLa/magainin.
2006,
Pubmed
,
Xenbase
Tucker,
Probing the kinetics of membrane-mediated helix folding.
2006,
Pubmed
,
Xenbase
Wade,
All-D amino acid-containing channel-forming antibiotic peptides.
1990,
Pubmed
,
Xenbase
Wakamatsu,
Dimer structure of magainin 2 bound to phospholipid vesicles.
2002,
Pubmed
,
Xenbase
Wenk,
Magainin 2 amide interaction with lipid membranes: calorimetric detection of peptide binding and pore formation.
1998,
Pubmed
,
Xenbase
Westerhoff,
Magainins and the disruption of membrane-linked free-energy transduction.
1989,
Pubmed
,
Xenbase
White,
Membrane protein folding and stability: physical principles.
1999,
Pubmed
Wieprecht,
Conformational and functional study of magainin 2 in model membrane environments using the new approach of systematic double-D-amino acid replacement.
1996,
Pubmed
,
Xenbase
Wieprecht,
Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes.
1997,
Pubmed
,
Xenbase
Wieprecht,
Binding of antibacterial magainin peptides to electrically neutral membranes: thermodynamics and structure.
1999,
Pubmed
,
Xenbase
Williams,
Raman spectroscopy of synthetic antimicrobial frog peptides magainin 2a and PGLa.
1990,
Pubmed
,
Xenbase
Wimley,
Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores.
1994,
Pubmed
Yandek,
Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers.
2007,
Pubmed
Yang,
Crystallization of antimicrobial pores in membranes: magainin and protegrin.
2000,
Pubmed
,
Xenbase
Zasloff,
Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.
1987,
Pubmed
,
Xenbase
Zasloff,
Antimicrobial activity of synthetic magainin peptides and several analogues.
1988,
Pubmed
,
Xenbase